Taxotere Lawsuit | Taxotere Eye Injury Lawsuit Update
- Last Updated: October 29th, 2025
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLawsuit Info and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLawsuit Info does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact our team by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Key Takeaways:
- Taxotere, a chemotherapy drug (used primarily for breast cancer treatment), has sparked numerous lawsuits due to severe side effects including permanent hair loss and eye injuries.
- The drug's manufacturer, Sanofi-Aventis, is accused of negligence for not adequately warning patients about these potential risks (while they continued to produce and distribute the drug).
- Despite over 10,000 legal claims filed against them, Sanofi-Aventis has yet to offer settlements to the victims of Taxotere.
Taxotere Eye Injury Lawsuit Overview
On this page we’ll discuss an overview of the Taxotere Lawsuit and what led to it, provide updates surrounding the Taxotere Eye Injury Lawsuit, review who qualifies for filing a Taxotere eye injury claim, and much more.
Intro to the Taxotere Eye Injury Lawsuit
Have you received Taxotere as part of your chemotherapy for breast cancer?
Have you experienced problems with your eyes?
If you have experienced eye problems and suspect that Taxotere is the culprit, you need to know that you’re not alone.
Thousands of women receiving Taxotere have reported the same issues — alongside others like permanent hair loss, nausea, and breathing difficulties, to name a few.
As a result, the women receiving the hazardous chemotherapy drug are suing the drug’s manufacturers.
We believe that no innocent person’s life should be at risk due to defective chemotherapy drugs.
That is why we encourage victims like yourself to come forward and take legal action.
If you received Taxotere around 2006 and have suffered from eye injuries because of this breast cancer chemotherapy drug, know that you may have a case.
Join many others in filing Taxotere lawsuits against the negligent manufacturers of this potentially hazardous drug.
In the meantime, learn more about the Taxotere lawsuit, the most recent Taxotere lawsuit update, and other vital information about the drug.
Also, read to the end to find out how you can take legal action and join the Taxotere multidistrict litigation (MDL).
Table of Contents
Lawsuit Updates
-
October 1st, 2025: October 2025 JPML Update
The Taxotere lawsuit experienced a modest rise between September and October, with total filings increasing from 364 to 369.
Although the multidistrict litigation (MDL) has progressed slowly, new filings continue to surface as awareness spreads and impacted patients come forward.
Plaintiffs allege that Sanofi failed to warn about the risk of permanent hair loss associated with Taxotere.
With case numbers holding steady, the Taxotere hair loss lawsuits remain active in the MDL process.
If you or a loved one experienced eye injuries or suffered vision loss after Taxotere use, you may be eligible to file a Taxotere Eye Injury Lawsuit and pursue financial compensation.
Contact TruLawsuit Info for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Eye Injury Lawsuit instantly.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Background on the Taxotere Lawsuits
Taxotere is a chemotherapy drug that has been around since the late 1980s.
Formulated and patented by Sanofi-Aventis, the drug was intended for breast cancer patients.
While the lawsuit we’re talking about involves the drug’s effects on the eyes, we need to talk about where it all began.
The lawsuits began after reports of permanent baldness from using Taxotere.
First, we’ll discuss the background of the Taxotere hair loss lawsuits.
The Taxotere Hair Loss Lawsuits
Taxotere’s efficacy in hindering the growth of cancer cells was consistent across various trials.
As a result, it didn’t take long for it to receive first-line use approval from the Food and Drugs Administration (FDA).
The drug finally received FDA approval for breast cancer treatment in 2004.
Less than a decade after its FDA approval, the chemotherapy drug Taxotere was the main drug of choice for more than one million breast cancer patients.
However, the popularity of Taxotere didn’t last long as patients began to suffer permanent hair loss.
As more patients receiving Taxotere developed permanent alopecia, the FDA took notice and warned Sanofi-Aventis and required the company to update its Taxotere warning label.
In 2015, Sanofi-Aventis updated the warning label to warn doctors and patients about the risk of permanent hair loss from using Taxotere.
However, by this time, the damage had already been done.
Thousands of women had already suffered from permanent hair loss.
The plaintiffs allege that Sanofi-Aventis was negligent in failing to warn patients of the drug’s risks sooner.
As a result, the first batch of lawsuits came as early as March 2016.
As more women filed their Taxotere hair loss lawsuits, there needed to be a way to efficiently process the cases.
In that same year, the Eastern District of Louisiana approved a petition for multidistrict litigation against Sanofi-Aventis.
Since the MDL’s approval, many patients who have experienced permanent hair loss have joined the Taxotere litigation.
It’s important to note that at the same time, many victims have joined the Taxotere class action lawsuit against Sanofi-Aventis.
The financially solvent multi-billion dollar company has been facing products liability litigation on two fronts.
The Taxotere Vision Damage Lawsuits
Permanent hair loss wasn’t the only complication resulting from the use of Taxotere.
During the same time as the Taxotere hair loss MDL, there were people filing Taxotere lawsuits for the drug’s effects on vision.
Taxotere caused various eye injuries in many of the plaintiffs who received the drug.
These problems ranged from lacrimal duct obstruction or tear duct blockage to more serious issues like docetaxel-induced cystoid macular edema.
These complications are the result of Taxotere chemotherapy — and Sanifi-Aventis knew this.
However, the company continued to manufacture and distribute this potentially hazardous chemo drug.
While Sanofi-Aventis didn’t deny knowing about the visual effects of Taxotere, plaintiffs allege that the company wasn’t fully transparent in informing the public of the risks.
More specifically, Sanofi-Aventis neglected to warn the public that Taxotere’s visual effects quickly progress and can be permanent.
This led to a separate Taxotere MDL being filed.
In 2022, the same court that approved the Taxotere MDL for those who suffered hair loss approved a second MDL for Taxotere-induced vision problems.
Updates on the Taxotere Lawsuit
After the second bellwether trial in 2021, the Eastern District of Louisiana approved another petition for a Taxotere MDL.
As a result, the Taxotere lawsuits entered the pre-trial phase in August 2022.
After the pre-trial phase, Judge Jane Triche Milazzo ordered a Science Day to take place on December 19, 2022.
Before that date, Judge Milazzo provided the protocols for the said Science Day.
Despite the scheduled date, the Science Day took place earlier.
There, the defendants Sanofi-Aventis presented their case refuting the claims made against them. Likewise, the legal counsel of the Taxotere lawsuit plaintiffs presented expert testimony and evidence to bolster the Taxotere claims.
After seeing the claims made by the plaintiffs as insufficient, Judge Milazzo ruled in favor of Sanofi-Aventis to dismiss the motion filed by the plaintiffs.
The Judge dismissed the case on December 5, 2022, on the grounds of a failure to state a claim.
Luckily, it was not the end of the road for the victims of the Taxotere case.
An appeals court overturned the December 2022 decision, bringing hope to the plaintiffs of the Taxotere vision loss lawsuit.
On February 13, 2023, Judge Milazzo issued a pre-trial order, officially setting the Taxotere eye injury MDL in motion again.
At the time of writing, the litigation against Sanofi-Aventis is ongoing.
There have been at least 10,000 more claims filed against the company. So far, recent rulings have been several Taxotere bellwether trials to determine settlements.
To date, Sanofi-Aventis hasn’t offered settlements to the victims of its chemo drug Taxotere.
Taxotere Side Effects: More than Meets the Eye
The broad range of Taxotere’s side effects highlights the necessity of regular monitoring and immediate intervention when adverse effects are detected.
Taxotere, a potent chemotherapeutic agent, has been associated with several serious eye-related side effects such as:
Lacrimal Duct Obstruction
A frequent side effect of Taxotere, Lacrimal Duct Obstruction is an eye condition that creates blockages in the tear ducts.
This leads to symptoms such as:
- Itchy eyes
- Persistent eye irritation
- Progression to corneal abrasions or scarring if untreated1
Docetaxel-induced Cystoid Macular Edema (DIME)
Many breast cancer patients receiving Taxotere therapy also developed DIME.
This condition is characterized by:
- Swelling in the macula, the central part of the retina responsible for detailed vision
- Gradual blurring of vision
- Significant vision loss in severe cases
Epiphora
Taxotere has been linked to the development of Epiphora, a condition that is a direct result of Lacrimal Duct Obstruction.
This condition causes:
- Tear accumulation within the ducts, leading to their swelling
- Extreme discomfort
- Excessive tearing
- Vision issues
Apart from these, Taxotere may also lead to other serious conditions such as neutropenia, anemia, febrile neutropenia, and thrombocytopenia.
Proper management can mitigate the severity of these side effects, thereby improving the patient’s quality of life during cancer treatment.
How To Take Legal Action and File a Vision Damage Lawsuit Against Sanofi-Aventis
Taking the proper steps in filing a Taxotere lawsuit is essential to your case’s success down the road.
If you have developed vision problems from taking Taxotere, follow these steps to maximize your chances of a successful vision damage claim.
Seek Medical Care for Your Vision Problems
Medical care is essential to halt the deterioration of your vision.
If you are under the care of an oncologist, you may be receiving care for your vision already since partial vision loss is a side-effect of other chemotherapy drugs.
Besides getting treatment for managing your vision, seeking medical attention enables you to secure various documents like your medical records and diagnostics.
These documents will be critical later when your lawyer represents you in your lawsuit against Sanofi-Aventis.
Retain Records of Your Prescriptions
Besides proving damages and injuries to your eyes, you must also prove that Taxotere was to blame.
To do this, you will need copies of your prescriptions.
Prescription records prove that you were taking Taxotere as part of your chemotherapy.
Having these will make it easier for your attorney to link Taxotere to your vision damage.
Contact a Law Firm for a Case Evaluation
Once you have the necessary documents, you can then find out if you qualify for a lawsuit.
One way to find out is by reaching out to a law firm.
Law firms usually offer case evaluations as part of their introductory services.
When you get one, you will find out if you have sufficient ground to file a lawsuit for your Taxotere-induced vision damage.
However, not every law firm or products liability litigation attorney will offer case evaluations for free.
If you need a free case evaluation, we can give you one.
You can get an instant case evaluation by clicking the “Do I Qualify” button below and find out if you qualify for the Taxotere Eye Injury Lawsuit!
Are You a Victim of Taxotere-Induced Vision Problems? Find Out if You Qualify for a Taxotere Lawsuit Now
If you have been receiving Taxotere as part of your chemotherapy treatments, you may risk vision problems — however, that’s not your fault.
With that in mind, you need to seek justice and do so immediately.
Don’t lose sight of your rights.
If you need a free resource or a free place to find out if you qualify for a case, we’re here.
We’ve helped thousands of victims like yourself by providing resources and case evaluations to aid in filing lawsuits.
Seek justice for yourself today.
Learn more about the Taxotere lawsuits and other active lawsuits.
Also, get a free case evaluation to determine your eligibility for a case.
Frequently Asked Questions
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Have A Case?
Here, at Tru Lawsuit Info, we’re committed to helping victims get the justice they deserve.
To do this, we actively work to connect them with attorneys who are experts in litigating cases similar to theirs.
Would you like our help?
Tru Lawsuit Info is a reliable source of information about issues that may affect your health and safety, such as faulty products, data breaches, and environmental hazards.
Our team of experienced writers collaborates with medical professionals, lawyers, and advocates to produce informative articles, guides, and other resources that raise awareness of these topics.
Our thorough research provides consumers with access to reliable information and updates on lawsuits happening around the country. We also can connect consumers with attorneys if they need assistance.
Camp Lejeune's water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Have A Case?
Here, at Tru Lawsuit Info, we’re committed to helping victims get the justice they deserve.
To do this, we actively work to connect them with attorneys who are experts in litigating cases similar to theirs.
Would you like our help?
